Labcorp Holdings [LH] vs Idexx Laboratories [IDXX] Detailed Stock Comparison
Labcorp Holdings
NYSE
Loading...
Idexx Laboratories
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Labcorp Holdings wins in 9 metrics, Idexx Laboratories wins in 10 metrics, with 0 ties. Idexx Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Labcorp Holdings | Idexx Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.67 | 53.75 | Labcorp Holdings |
| Price-to-Book Ratio | 2.72 | 35.47 | Labcorp Holdings |
| Debt-to-Equity Ratio | 77.78 | 84.81 | Labcorp Holdings |
| PEG Ratio | 1.83 | 1.10 | Idexx Laboratories |
| EV/EBITDA | 15.96 | 37.85 | Labcorp Holdings |
| Profit Margin (TTM) | 5.66% | 24.41% | Idexx Laboratories |
| Operating Margin (TTM) | 11.30% | 33.62% | Idexx Laboratories |
| EBITDA Margin (TTM) | 11.30% | 33.62% | Idexx Laboratories |
| Return on Equity | 9.26% | 64.87% | Idexx Laboratories |
| Return on Assets (TTM) | 4.44% | 23.26% | Idexx Laboratories |
| Free Cash Flow (TTM) | $1.10B | $798.08M | Labcorp Holdings |
| Dividend Yield | 0.83% | N/A | N/A |
| 1-Year Return | 20.48% | 32.25% | Idexx Laboratories |
| Price-to-Sales Ratio (TTM) | 1.71 | 12.79 | Labcorp Holdings |
| Enterprise Value | $29.09B | $52.72B | Idexx Laboratories |
| EV/Revenue Ratio | 2.16 | 13.06 | Labcorp Holdings |
| Gross Profit Margin (TTM) | 29.66% | 62.62% | Idexx Laboratories |
| Revenue per Share (TTM) | $161 | $50 | Labcorp Holdings |
| Earnings per Share (Diluted) | $9.07 | $12.01 | Idexx Laboratories |
| Beta (Stock Volatility) | 0.76 | 1.50 | Labcorp Holdings |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Labcorp Holdings vs Idexx Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Labcorp Holdings | -0.74% | 2.88% | 10.36% | 15.00% | 10.64% | 21.91% |
| Idexx Laboratories | -0.65% | -0.81% | 21.34% | 27.87% | 39.23% | 57.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Labcorp Holdings | 20.48% | 41.30% | 82.52% | 170.71% | 330.49% | 559.82% |
| Idexx Laboratories | 32.25% | 84.50% | 68.12% | 781.78% | 2,165.09% | 3,944.80% |
Performance & Financial Health Analysis: Labcorp Holdings vs Idexx Laboratories
| Metric | LH | IDXX |
|---|---|---|
| Market Information | ||
| Market Cap | $23.12B | $51.65B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 517,640 | 449,320 |
| 90 Day Avg. Volume | 710,647 | 700,030 |
| Last Close | $276.11 | $641.35 |
| 52 Week Range | $209.38 - $283.47 | $356.14 - $688.12 |
| % from 52W High | -2.60% | -6.80% |
| All-Time High | $283.47 (Jul 24, 2025) | $706.95 (Jul 26, 2021) |
| % from All-Time High | -2.60% | -9.28% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.11% |
| Quarterly Earnings Growth | 0.16% | 0.45% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.24% |
| Operating Margin (TTM) | 0.11% | 0.34% |
| Return on Equity (TTM) | 0.09% | 0.65% |
| Debt to Equity (MRQ) | 77.78 | 84.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $102.20 | $18.20 |
| Cash per Share (MRQ) | $7.79 | $2.06 |
| Operating Cash Flow (TTM) | $1.69B | $905.81M |
| Levered Free Cash Flow (TTM) | $1.03B | $625.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.83% | N/A |
| Last 12-Month Dividend | $2.16 | N/A |
Valuation & Enterprise Metrics Analysis: Labcorp Holdings vs Idexx Laboratories
| Metric | LH | IDXX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.67 | 53.75 |
| Forward P/E | 17.36 | 53.98 |
| PEG Ratio | 1.83 | 1.10 |
| Price to Sales (TTM) | 1.71 | 12.79 |
| Price to Book (MRQ) | 2.72 | 35.47 |
| Market Capitalization | ||
| Market Capitalization | $23.12B | $51.65B |
| Enterprise Value | $29.09B | $52.72B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.16 | 13.06 |
| Enterprise to EBITDA | 15.96 | 37.85 |
| Risk & Other Metrics | ||
| Beta | 0.76 | 1.50 |
| Book Value per Share (MRQ) | $102.20 | $18.20 |
Financial Statements Comparison: Labcorp Holdings vs Idexx Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LH | IDXX |
|---|---|---|
| Revenue/Sales | $3.35B | $998.43M |
| Cost of Goods Sold | $2.40B | $375.05M |
| Gross Profit | $948.00M | $623.38M |
| Research & Development | N/A | $59.06M |
| Operating Income (EBIT) | $332.40M | $316.53M |
| EBITDA | $497.90M | $351.81M |
| Pre-Tax Income | $275.20M | $310.08M |
| Income Tax | $62.20M | $67.41M |
| Net Income (Profit) | $213.00M | $242.68M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LH | IDXX |
|---|---|---|
| Cash & Equivalents | $369.40M | $163.97M |
| Total Current Assets | $3.79B | $1.32B |
| Total Current Liabilities | $2.06B | $1.14B |
| Long-Term Debt | $6.33B | $546.80M |
| Total Shareholders Equity | $8.32B | $1.45B |
| Retained Earnings | $8.46B | $5.58B |
| Property, Plant & Equipment | N/A | $833.62M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LH | IDXX |
|---|---|---|
| Operating Cash Flow | $148.20M | $235.07M |
| Capital Expenditures | N/A | $-30.03M |
| Free Cash Flow | $-107.50M | $207.94M |
| Debt Repayment | $-1.06B | N/A |
| Common Stock Repurchase | N/A | $-400.89M |
Short Interest & Institutional Ownership Analysis
| Metric | LH | IDXX |
|---|---|---|
| Shares Short | 2.75M | 2.48M |
| Short Ratio | 3.24 | 4.68 |
| Short % of Float | 0.04% | 0.04% |
| Average Daily Volume (10 Day) | 517,640 | 449,320 |
| Average Daily Volume (90 Day) | 710,647 | 700,030 |
| Shares Outstanding | 83.40M | 81.60M |
| Float Shares | 82.66M | 79.12M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.00% | 0.98% |
Dividend Analysis & Yield Comparison: Labcorp Holdings vs Idexx Laboratories
| Metric | LH | IDXX |
|---|---|---|
| Last 12-Month Dividend | $2.16 | N/A |
| Last 12-Month Dividend Yield | 0.83% | N/A |
| 3-Year Avg Annual Dividend | $2.75 | N/A |
| 3-Year Avg Dividend Yield | 0.32% | N/A |
| 3-Year Total Dividends | $8.24 | N/A |
| Ex-Dividend Date | Feb 27, 2025 | N/A |